Minocycline: An Old Drug for a New Bug: Multidrug-Resistant Acinetobacter baumannii

November 30, 2014 at 8:07 pm

Clinical Infectious Diseases December 1, 2014 V.59 suppl 6  S365-S366

Debra A. Goff1 and Keith S. Kaye2,3

1Department of Pharmacy, The Ohio State University Wexner Medical Center, Columbus

2Department of Medicine, Division of Infectious Diseases, Detroit Medical Center

3Wayne State University School of Medicine, Detroit, Michigan

Correspondence: Debra A. Goff, PharmD, FCCP, The Ohio State University Wexner Medical Center, Department of Pharmacy, 410 W 10th Ave, Rm 368 Doan Hall, Columbus, OH 43210 (debbie.goff@osumc.edu).

Acinetobacter baumannii is listed in the Centers for Disease Control and Prevention’s (CDC) report “Antibiotic Resistance Threats in the United States, 2013” as 1 of 18 microorganisms whose threat level is “urgent,” “serious,” or “concerning” according to their current and projected health and economic impacts [1].

The A. baumannii threat level is ranked as “serious” and carries a warning that this organism requires prompt and sustained action by healthcare providers to ensure that this problem pathogen does not continue to become more resistant to antimicrobials and spread.

The CDC estimates that nearly 7000 of 12 000 (63%) healthcare-associated Acinetobacter infections are multidrug resistant (MDR), defined as resistance to ≥3 different classes of antimicrobials.

Hospitals around the world are witnessing the loss of antibiotics for the treatment of MDR A. baumannii (MDR-AB) infections [2].

The lack of clinically effective antimicrobials to treat A. baumannii infections has led clinicians to reevaluate other “older” agents for the treatment of MDR-AB…..



Entry filed under: Antimicrobianos, Bacterias, Bacteriemias, Health Care-Associated Infections, Infecciones nosocomiales, Metodos diagnosticos, Resistencia bacteriana. Tags: .

Are antibiotics indicated for the treatment of aspiration pneumonia? Update on Acinetobacter Species: Mechanisms of Antimicrobial Resistance and Contemporary In Vitro Activity of Minocycline and Other Treatment Options


November 2014
« Oct   Dec »

Most Recent Posts

%d bloggers like this: